Moreover, Rg1 and Rb1 treatment dramatically attenuated mitochondrial damage, reduced ROS production, inhibited neural cell apoptosis, and activated the BDNF-TrKB/PI3K-Akt signaling pathway in the PFCs of HLS model rats. The gene discussed is NTRK2; the disease is Hydrolethalus.